Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity

Archives of Biochemistry and Biophysics

Volumn 331, Issue 2, 1996, Pages 145-169

  Pearce, Robin E ^a   McIntyre, Christin J ^a   Madan, Ajay ^a   Sanzgiri, Uma ^a   Draper, Alison J ^a   Bullock, Peter L ^a,d   Cook, Dorn C ^b   Burton, L Alayne ^c   Latham, Jason ^c   Nevins, Cheryl ^c   Parkinson, Andrew ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b Human Biologics Incorporated   (United States)

^c XenoTech LLC   (United States)

^d MDS Inc   (Canada)

Author keywords

cytochrome P450; human liver microsomes; stability

Indexed keywords

CAFFEINE; CHLORZOXAZONE; COUMARIN ANTICOAGULANT; CYTOCHROME B5; CYTOCHROME P450; DEXTROMETHORPHAN; ETHOXYRESORUFIN; LAURIC ACID; MEPHENYTOIN; MICROSOME ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; TESTOSTERONE; TOLBUTAMIDE;

ADULT; ARTICLE; BIOTRANSFORMATION; CLINICAL ARTICLE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; FREEZING; HUMAN; HUMAN TISSUE; INFANT; LIVER MICROSOME; MALE; ORGAN DONOR; ORGAN PRESERVATION; PRIORITY JOURNAL; THAWING; XENOBIOTIC METABOLISM;

EID: 0030586368     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1996.0294     Document Type: Article

References (61)

1. 1. Wrighton, S. A., Vandenbranden, M., Stevens, J. C., Shipley, L. A., Ring, B. J., Rettie, A. E., and Cashman, J. R. (1993) Drug Metab. Rev. 25, 453-484.
2. 2. Guengerich, F. P. (1989) Annu. Rev. Pharmacol. Toxicol. 29, 241-264.
3. 3. Parkinson, A. (1995) in Casarett and Doull's Toxicology. The Basic Science of Poisons (Klaassen, C. D., Ed.), 5th ed., pp. 113-186, McGraw-Hill, New York.
4. 4. Reinke, L. A., and Stohs, S. J. (1976) Res. Commun. Chem. Pathol. Pharmacol. 14, 295-303.
5. 5. Tredger, J. M., and Chhabra, R. S. (1976) Drug Metab. Dispos. 4, 451-459.
6. 6. Bartosek, I., Dolfini, E., Ghersa, P., Guaitani, A., Villa, P., and Villa, S. (1980) J. Pharmacol. Methods 3, 191-200.
7. 7. Leadbeater, L., and Davies, D. R. (1964) Biochem. Pharmacol. 13, 1607-1617.
8. 8. Wade, A. E., Wu, B., and Greene, F. E. (1972) Toxicol. Appl. Pharmacol. 22, 503-512.
9. 9. Hewick, D. S., and Fouts, J. R. (1970) Biochem. Pharmacol. 19, 457-472.
10. 10. Levin, W., Alvares, A., Jacobson, M., and Kuntzman, R. (1969) Biochem. Pharmacol. 18, 883-889.
11. 11. Crankshaw, D. L., Erikson, R. R., and Holtzman, J. L. (1990) Biochem. Pharmacol. 39, 393-396.
12. 12. Litterst, C. L., Mimnaugh, E. G., Regan, R. L., and Gram, T. E. (1974) Biochem. Pharmacol. 23, 2391-2394.
13. 13. Danner-Rabovsky, J., and Groseclose, R. D. (1982) J. Toxicol. Environ. Health 10, 601-611.
14. 14. Bode, C., and Meinel, A. (1982) J. Clin. Chem. Clin. Biochem. 20, 9-13.
15. 15. Kim, S. Y., and Park, K. H. (1988) Korean Biochem. J. 21, 505-511.
16. 16. Ohmiya, Y., and Mehendale, H. M. (1984) Jpn. J. Pharmacol. 36, 256-257.
17. 17. Bulger, W. H., and Stohs, S. J. (1975) Res. Commun. Chem. Pathol. Pharmacol. 11, 467-474.
18. 18. Tauc, M., Hermann, M., Dansette, P. M., and Vandecasteele, J. P. (1984) Mut. Res. 125, 123-133.
19. 19. Hubbard, S. A., and Davis, P. J. B. (1990) Mutagenesis 5, 7-8.
20. 20. Bauer, C., Corsi, C., and Paolini, M. (1994) Teratogen. Carcinogen. Mutagen. 14, 13-22.
21. 21. Powis, G., Jardine, I., Van Dyke, R., Weinshilboum, R., Moore, D., Wilke, T., Rhodes, W., Nelson, R., Benson, L., and Szumlanski, C. (1988) Drug Metab. Dispos. 16, 582-589.
22. 22. Lu, A. Y. H., and Levin, W. (1972) Biochem. Biophys. Res. Commun. 46, 1334-1339.
23. 23. BCA Protein Assay Reagent (1991) in Technical Bulletin 23225X from Pierce Chemical Co., pp. 1-16.
24. 24. Omura, T., and Sato, R. (1964) J. Biol. Chem. 239, 2379-2385.
25. 25. Matsubara, T., Koike, M., Touchi, A., Tochino, Y., and Sugeno, K. (1976) Anal. Biochem. 75, 596-603.
26. 26. Guengerich, F. P. (1989) in Principles and Methods of Toxicology, 2nd ed., pp. 777-814, Raven Press, New York.
27. 27. Phillips, A. H., and Langdon, R. G. (1962) J. Biol. Chem. 237, 2652-2660.
28. 28. Burke, M. D., and Mayer, R. T. (1974) Drug Metab. Dispos. 2, 583-588.
29. 29. Button, D. R., and Parkinson, A. (1989) Arch. Biochem. Biophys. 268, 617-629.
30. 30. Pearce, R., Greenway, D., and Parkinson, A. (1992) Arch. Biochem. Biophys. 298, 211-225.
31. 31. Greenlee, W. F., and Poland, A. (1978) J. Pharmacol. Exp. Ther. 205, 596-605.
32. 32. Naline, E., Flouvat, B., Advenier, C., and Pays, M. (1987) J. Chromatogr. 419, 177-189.
33. 33. Meier, U. T., Bayer, P., Malè, P. J., Kronbach, T., and Meyer, U. R. (1985) Clin. Pharmacol. Ther. 38, 488-494.
34. 34. Knodell, R. G., Hall, S. D., Wilkinson, G. R., and Guengerich, F. P. (1987) J. Pharmacol. Exp. Ther. 241, 1112-1119.
35. 35. Kronbach, T. (1991) Methods Enzymol. 206, 509-517.
36. 36. Peter, R., Böcker, R., Beaune, P. H., Iwasaki, M., Guengerich, F. P., and Yang, C. S. (1990) Chem. Res. Toxicol. 3, 566-573.
37. 37. Wood, A. W., Ryan, D. E., Thomas, P. E., and Levin, W. (1983) J. Biol Chem. 258, 8839-8847.
38. 38. Sonderfan, A. J., Arlotto, M. P., Dutton, D. R., McMillen, S. K., and Parkinson, A. (1987) Arch. Biochem. Biophys. 255, 27-41.
39. 39. Sonderfan, A. J., and Parkinson, A. (1988) Arch. Biochem. Biophys. 265, 208-218.
40. 40. Arlotto, M. P., Greenway, D. J., and Parkinson, A. (1989) Arch. Biochem. Biophys. 270, 441-457.
41. 41. Smith, S., Korzekwa, K. R., Aoyama, T., Gonzalez, F. J., Darbyshire, J. F., Sugiyama, K., and Gillette, J. R. (1992) Drug Metab. Dispos. 20, 566-571.
42. 42. Giera, D. D., and van Lier, R. B. (1991) Fundam. Appl. Toxicol. 16, 348-355.
43. 43. Romano, M. C., Straub, K. M., Yodis, L. A. P., Eckardt, R. D., and Newton, J. F. (1988) Anal. Biochem. 170, 83-93.
44. 44. Bruning, J. L., and Kintz, B. L. (1987) in Computational Handbook of Statistics, 3rd ed., pp. 176-180, Harper Collins, IL.
45. 45. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. P. (1994) J. Pharmacol. Exp. Ther. 270, 414-423.
46. 46. Guengerich, F. P., and Turvy, C. G. (1991) J. Pharmacol. Exp. Ther. 256, 1189-1194.
47. 47. Forrester, L. M., Henderson, C. J., Glancey, M. J., Back, D. J., Park, K. B., Ball, S. E., Kitteringham, N. R., McLaren, A. W., Miles, J. S., Skett, P., and Wolf, C. R. (1992) Biochem. J. 281, 359-368.
48. 48. Gu, L., Gonzalez, F. J., Kalow, W., and Tang, B. K. (1992) Pharmacogenetics 2, 73-77.
49. 49. Brian, W. R., Srivastava, P. K., Umbenhauer, D. R., and Lloyd, R. (1989) Biochemistry 28, 4993-4999.
50. 50. Srivastava, P. K., Yun, C-H., Beaune, P. H., Ged, C., and Guengerich, F. P. (1991) Mol. Pharmacol. 40, 69-79.
51. 51. Relling, M. V., Aoyama, T., Gonzalez, F. J., and Meyer, U. A. (1990) J. Pharmacol. Exp. Ther. 252, 442-447.
52. 52. Sandhu, P., Baba, T., and Guengerich, F. P. (1993) Arch. Biochem. Biophys. 306, 443-450.
53. 53. Wrighton, S. A., Stevens, J. C., Becker, G. W., and VandenBranden, M. (1993) Arch. Biochem. Biophys. 306, 240-245.
54. 54. Goldstein, J. A., Faletto, M. B., Romkes-Sparks, M., Sullivan, T., Kitareewan, S., Raucy, J. L., Lasker, J. M., and Ghanayem, B. I. (1994) Biochemistry 33, 1743-1752.
55. 55. Schmid, B., Bircher, J., Preisig, R., and Kupfer, A. (1985) Clin. Pharmacol. Ther. 38, 618-624.
56. 56. Waxman, D. J., Attisano, C., Guengerich, F. P., and Lapenson, D. P. (1988) Arch. Biochem. Biophys. 263, 424-436.
57. 57. Wrighton, S. A., Brian, W. R., Sari, M-A., Iwasaki, M., Guengerich, F. P., Raucy, J. L., Molowa, D. T., and VandenBranden, M. (1990) Mol. Pharmacol. 38, 207-213.
58. 58. Wrighton, S. A., Ring, B. J., Watkins, P. B., and VandenBranden, M. (1989). Mol. Pharmacol. 36, 97-105.
59. 59. Wrighton, S. A., and VandenBranden, M. (1989) Arch. Biochem. Biophys. 268, 144-151.
60. 60. Dirven, H. A. M., Peters, J. G. P., Gibson, G. G., Peters, W. H. M., and Jongeneelen, F. J. (1991) Biochem. Pharmacol. 42, 1841-1844.
61. 61. Kawashima, H., Kusunose, E., Kikuta, Y., Kinoshita, H., Tanaka, S., Yamamoto, S., Kishimoto, T., and Kusunose, M. (1994) J. Biochem. (Tokyo) 116, 74-80.